Medication info

Ezevatin Tablet 10/10mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Lightpharmtech Co., Ltd.
Appearance
White to pale yellow, double convex, rectangular tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu X 3]
Approval status
Expired

MFDS item code 201907092 · Approved 2019.10.07

This product's status changed to Expired on 2024.10.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start with 10/10mg once daily. After starting treatment with this drug or adjusting the dose, check blood lipid levels and adjust the dose at intervals of 4 weeks or longer. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL Apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment, but use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use higher doses of this drug with caution in these patients and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 6. Interactions.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Lightpharmtech Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used as an adjunct to diet for lowering total cholesterol, bad LDL cholesterol, apolipoprotein B, and triglycerides while raising good HDL cholesterol in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial hypercholesterolemia, as well as mixed hyperlipidemia. In homozygous familial hypercholesterolemia patients, it is administered when other treatments are ineffective or as an adjunct therapy. This medication should be used in conjunction with an appropriate diet and should be administered with caution while considering other health conditions and risk factors. Additionally, it is important to verify and treat any secondary causes such as diabetes or hypothyroidism before starting this medication. Accurate assessment of cholesterol and lipid levels is necessary for the prevention of cardiovascular diseases. This medication effectively treats hypercholesterolemia and improves vascular health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start with 10/10mg once daily. After starting treatment with this drug or adjusting the dose, check blood lipid levels and adjust the dose at intervals of 4 weeks or longer. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL Apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment, but use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use higher doses of this drug with caution in these patients and monitor them closely (see Precautions for Use, 5. General Precautions). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 6. Interactions.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication helps lower blood cholesterol levels. However, caution is needed as muscle problems may arise while taking this medication. If muscle pain, weakness, or swelling occurs, inform your doctor immediately. Muscle issues may occur more frequently, especially when taking this medication at high doses or in conjunction with certain other drugs. This medication can affect liver function, so it should not be used in patients with liver disease or elevated liver enzymes. Women who are pregnant or breastfeeding should not take this medication. Additionally, it should not be taken by individuals with an allergy to this medication or certain genetic lactose intolerance. Since this medication may interact with other drugs, anyone currently taking other medications should inform their doctor or pharmacist. During treatment, it is advisable to regularly check liver function and muscle condition through blood tests. If unexplained muscle pain or weakness persists during treatment, consult a medical professional immediately. This medication should also be used cautiously in children and elderly individuals, and is especially not recommended for children under 10 years old. There is no specific antidote for overdose, so it is important to adhere strictly to the dosage.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 99 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • lumbar pain
  • cough
  • hypersensitivity reaction
  • angioedema
  • rash
  • pancreatitis
  • nausea
  • cholelithiasis
  • cholecystitis
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • pruritus
  • eczema
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • taste disturbance
  • ocular muscle movement disorder
  • facial weakness
  • tremor
  • dizziness
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • depression
  • cognitive dysfunction
  • interstitial lung disease
  • anaphylaxis
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • hepatitis
  • obstructive jaundice from bile stasis
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • hepatocellular carcinoma
  • hepatic failure
  • loss of appetite
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; it should be stored in a tightly sealed container. It is also advisable to keep it at room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White to pale yellow, double convex, rectangular tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.